Peter Schmid, DO
Otolaryngology · Longmont, CONPI 1306885165
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,000 of the $44,797 with a category attached, or 93.8%. AbbVie accounts for 96.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $12,493 and has fallen 95.8% since, to $522 in 2025. Among otolaryngology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 110 payments — averaging $407.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$43K
- Apyx Medical Corporation$432
- Galderma Laboratories, L.p.$222
- Stryker$188
- Aerin Medical Inc.$168
- Merz North America, Inc.$167
- plus $325 from 3 others
What the payments were for
- Speaking & faculty fees$42,00094%
- Food & beverage$2,7466%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 90 | $43,295 |
| Apyx Medical Corporation | 4 | $432 |
| Galderma Laboratories, L.p. | 8 | $222 |
| Stryker | 2 | $188 |
| Aerin Medical Inc. | 1 | $168 |
| Merz North America, Inc. | 2 | $167 |
| Johnson & Johnson | 1 | $135 |
| Sanofi-aventis U.S. LLC | 1 | $125 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $64 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$3,127
- BOTOX$2,500
- ENTELLUS - XPRESS ENT DILATION SYSTEM$168
- VIVAER STYLUS$168
- RHINAER STYLUS$168
- MATRIXMIDFACE$135
- DISEASE STATE$125
How this compares
$44,797 in reported general payments places this provider in the 95th percentile of 174 otolaryngology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 65 | $352 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 44 | $169 |
| ValacyclovirValacyclovir Hcl | 11 | $137 |
| Methylprednisolone | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Longmont
- Abby EmdurLongmont$4K
- Jessica SpechtLongmont$2K
- Suzanne BertramFort Collins$475K
- Barton KnoxColorado Springs$164K
- Nicholas BeckmannColorado Springs$151K
- Vijay RamakrishnanAurora$128K
- Michael WilhelmColorado Springs$76K
- Andrew WinklerAurora$68K
- David OppermanDenver$67K
- Robert KellerColorado Springs$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.